Phase II study of hydroxyurea administered intermittently in malignant melanoma.
D000328:Adult; D000368:Aged; D002908:Chronic Disease; D005260:Female; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage* / Q000009:adverse effects; D007958:Leukocyte Count; D007970:Leukopenia; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000601:surgery; D008875:Middle Aged; D009362:Neoplasm Metastasis
D006918:Hydroxyurea